This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Reducing Slow/No-Reflow With Prophylactic High-Dose Intracoronary Adenosine Protocol in ST-Elevation Myocardial Infarction The REFLOW AMI Trial | MicrobiomeTrials
← Back to trials NCT07898696
Reducing Slow/No-Reflow With Prophylactic High-Dose Intracoronary Adenosine Protocol in ST-Elevation Myocardial Infarction The REFLOW AMI Trial Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-08-14Est. Completion: 2027-08-14
Enrollment target: 660 participantsLocations Punjab institute of cardiology Lahore, Lahore, Punjab Province, Pakistan Dow University of Health Sciences,Karachi, Karachi, Sindh, Pakistan Other microbiome trials you might be interested in Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) Acute Coronary Syndromes ST-segment Elevation Myocardial Infarction (STEMI) Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
This study will evaluate whether an OCR-LLM-based clinical decision support framework improves clinicians' accuracy in c…
Beijing, China Completed Mar 8, 2026
Acute Myocardial Infarction
This study will randomize patients recently discharged from the hospital with a confirmed diagnosis of type 1 acute myoc…
Alexander City, United States
Completed Jul 2027